News
Darshin Patel discusses the first-of-its-kind Sapien M3 TMVR system's design, development and lessons for other medical ...
Using the latest data and perspectives, an international expert panel releases updated recommendations for optimal insulin ...
The May 2025 issue of Medical Design & Outsourcing features next-gen inhalable vaccine delivery, type 2 diabetes tech and ...
EOS GmbH, headquartered in Krailling, Germany, has announced its latest advancement in regulatory compliance support for ...
This article explores the global regulatory landscape, examining how leading authorities in the U.S., EU, U.K., Canada, China, Brazil, Australia, and South Korea are approaching AI in medical devices.
We consider Ansys to exhibit medium uncertainty. The company exhibits relatively low revenue cyclicality, growth is somewhat predictable given the company’s steady contracts, and good margins combined ...
A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results